Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
DIAGNOSTIC TESTS
1. 2. 3. 4. 5. 6. 12-Lead Electrocardiogram Cardiac Marker Studies Echocardiography Cardiac Catheterization Hemodynamic Monitoring Cardiac Output Monitoring
ELECTROCARDIOGRAM
(ECG)
ELECTROCARDIOGRAM (ECG)
It is the most valuable and commonly used diagnostic tool in assessing the cardiovascular system. It measures the hearts electrical activity and records it. A graphic recording of the electrical impulses of the heart.
12 LEAD ECG
Unipolar Limb Leads RA: Red LA: Yellow LL: Green RL: Black Bipolar Standard Limb Leads Leads I, II , III Unipolar Augmented Leads Leads aVR, aVL, aVF
P Q
S
DEFINITION OF TERMS
INOTROPIC EFFECT change in myocardial contractility CHRONOTROPIC EFFECT change in heart rate DROMOTROPIC EFFECT change in speed of conduction through the AV junction.
EKG PAPER
The EKG (Electrocardiogram) graph paper is where the heart rhythm is printed where it can be analyzed carefully and treated accordingly. EKG interpretation takes a bit of skill because there are certain EKG rhythm print outs that are difficult to identify.
THE WAVEFORMS
WAVEFORM movement away from the baseline in either a positive of negative direction. SEGMENT a line between wave forms. INTERVAL consists of a waveform and a segment. COMPLEX consists of several waveforms.
THE WAVEFORMS
P WAVE atrial depolarization/systole. PR SEGMENT AV node conduction. PR INTERVAL begins with the onset of the P wave and ends with the on of the QRS complex. QRS COMPLEX ventricular depolarization. ST SEGMENT begins with the end of the QRS complex and ends with the onset of the T wave. T WAVE ventricular repolarization. QT INTERVAL from the beginning of the QRS complex to the end of the T wave. U WAVE repolarization of the Purkinje fibers.
Hearts original electrical impulse (normal pacemaker) originates from the SA node spreading through the atrial muscles called ATRIAL DEPOLARIZATION.
The electrical impulse spreads through the ventricles (Bundle of His) is called VENTRICULAR DEPOLARIZATION.
1 small box = 1 mm = 0.04 sec 1 large box = 5 small boxes = 5mm = 0.20sec 5 large boxes = 25 small boxes = 1 sec 30 large boxes = 150 small boxes = 6 secs
Using a caliper, measure the distance between P P and R R. Regular rhythm: BOTH P P and R R intervals are EQUAL.
HEART RATE =
, #
300
1 big box = 300 beats/min (duration = 0.2 sec) 2 big boxes = 150 beats/min (duration = 0.4 sec) 3 big boxes = 100 beats/min (duration = 0.6 sec) 4 big boxes = 75 beats/min (duration = 0.8 sec) 5 big boxes = 60 beats/min (duration = 1.0 sec)
214 187 167 150 136
125 115 107 100 94 88 83 79 75 71 68 65 62 60
250
SINUS BRADYCARDIA
Configuration: P wave upright, uniform in shape; QRS complex and T wave upright Rate: Below 60bpm Rhythm: Regular (-cardia)
Sinus Bradycardia
1. 2. 3. 4. 5. 6. 7.
SIGNS & Endocarditis SYMPTOMS Heart attack Dizziness Hypothyroidism Fainting CAD Fatigue Heart surgery Increased ICP Shortness of Increased vagal tone due to bowel breath straining, vomiting, mech.ventilation / Palpitations intubation
CAUSES
TREATMENT: S. BRADYCARDIA
No treatment needed (patient is usually asymptomatic); if drugs are cause, possible discontinuation. Temporary pacemaker and atropine for low cardiac output, dizziness, weakness, altered LOC, or low BP Dopamine or epinephrine infusion, if indicated Temporary or permanent pacemaker may be needed if condition becomes chronic
SINUS TACHYCARDIA
Configuration: P wave small and upright; QRS complex and T wave normal Rate: Over 100 bpm Rhythm: Regular (-cardia)
TREATMENT: S. TACHYCARDIA
No treatment necessary if patient is asymptomatic Correction of the underlying cause Beta-adrenergic blocker or CCB, if cardiac ischemia occurs
SINUS ARREST
Configuration: Normal P wave preceding each normal QRS complex Rhythm: Regular, except for missing PQRST
TREATMENT: S. ARREST
No treatment needed if patient is asymptomatic For mild symptoms, possible discontinuation of drugs that contribute to arrhythmia Atropine, if patient is symptomatic Temporary or permanent pacemaker for repeated episodes
ATRIAL TACHYCARDIA/SVT
Configuration: No definite P wave; QRS and T wave normal; sudden onset and termination of arrhythmia Rate: 150-250 bpm Rhythm: Regular
TREATMENT: A. TACHYCARDIA
Vagal stimulation, carotid sinus massage Priority is decreasing ventricular response with CCB, beta-adrenergic blocker, digoxin, or cardioversion If other treatment are ineffective, amiodarone or procainamide
ATRIAL FIBRILLATION
Configuration: No definite P wave, only a chaotic rhythm (not sure if its a P wave or T); no PR interval; QRS normal Rate: Atrial rate >400 bpm; depends on the ventricular response Rhythm: Not only irregular but highly irregular
NOTES: - AF or fibrillating (quivering) 7x risk for stroke - Given anticoagulant or electrical cardioversion Controlled or slow HR is less than 100bpm Uncontrolled or fast HR is more than 100bpm
TREATMENT: A. FIBRILLATION
Treatment of underlying cause CCB or beta-adrenergic blocker, if stable and heart functions normally Amiodarone, ibutilide, flecainide, propafenone, or procainamide, if arrhythmia is present for less than 48 hours Synchronized cardioversion (treatment of choice) Anticoagulation prior to cardioversion Ablation therapy for recurrent rhythm
ATRIAL FLUTTER
Configuration: No definite P, flutter waves looks like saw tooth or picket fence ; QRS - identifiable Rate: Atrial rate 250-400 bpm; ventricular rate dependent on degree of AV block Rhythm: Atrial rhythm regular; ventricular rhythm variable, dependent on degree of AV block
TREATMENT: A. FLUTTER
SAME with A. Fibrillation
Premature, abnormal P waves (differ in configuration form normal P waves) QRS complexes after P waves, except in blocked PACs P wave commonly buried or identified in preceding T wave
TREATMENT: PAC
No treatment needed if patient is asymptomatic Beta-adrenergic blockers, CCBs, or digoxin, if occurs frequently Treatment of underlying cause; avoidance or triggers (caffeine or smoking) and use of stress-reduction measures
Rhythm: Regular Rate: 40-60 bpm Configuration: P waves before, hidden in, or after QRS complex, inverted if visible; PR interval <0.12 seconds; QRS normal
JUNCTIONAL TACHYCARDIA
Rhythm: Regular Rate: 100-200 bpm Configuration: P waves before, hidden in, or after QRS complex, inverted if visible; QRS normal
TREATMENT: J. TACHYCARDIA
Correction of underlying cause Discontinuation of digoxin, if applicable and appropriate Vagal maneuvers, adenosine, amiodarone, beta-adrenergic blocker, CCBs to slow rate Ablation therapy, if recurrent, followed by insertion of permanent pacemaker
Atrioventricular Blocks
R P Q S T
R P T
Q
Do you have a normal P wave? Do you have a normal PR segment? Do you have a normal PR interval? Do you have a normal QRS-T?
0.28 sec
0.28 sec
0.28 sec
0.20 sec
0.28 sec
0.20 sec
Trifascicle
0.18 sec
0.18 sec
0.18 sec
Yes
VENTRICULAR TACHYCARDIA
Configuration: No P and T wave, wide bizarre QRS noted; may start and stop suddenly Rate: Ventricular rate of 100-250 bpm Rhythm: Atrial rhythm cant be determined; ventricular rhythm usually regular, may be slightly irrregular
TREATMENT: V. TACHYCARDIA
If patient is pulseless, immediate defibrillation and resuscitation If episodes of VT unresponsive to drugs recur, may need a cardioverterdefibrillator
Configuration is rapid, chaotic, disorganized ventricular contractions. No P nor T. No normal looking QRS, the ventricles do not contract as a unit wherein the myocardium appears to be just quivering. NO CARDIAC OUTPUT. Rate: Hard to determine accurately Rhythm: Highly irregular
Configuration: No P and T wave, almost or totally absent QRS complex Rate and Rhythm: Questionable Also known as COARSE ASYSTOLE
TREATMENT: V. FIBRILLATION
Rapid resuscitation defibrillation and COR Epinephrine or vasopressin followed by defibrillation and CPR Implantable cardioverter-defibrillator, if at risk for recurrent ventricular fibrillation Treatment of underlying causes
Configuration: Absent P wave, wide and bizarre QRS, questionable T wave Rate: 40 bpm (up to 100 for accelerated IVR) Rhythm: Regular or slightly irregular
Pacemaker Rhythm
No P wave (ventricular impulse origin) Wide QRS complex (>0.10 sec) Pacemaker spike precede the wide
QRS complexes
HEART ENZYMES:
Creatine kinase (CK) and its isoenzyme MB AND lactate dehydrogenase (LD) and its isoenzyme LD1 and LD2. Troponin T and I and myoglobin are more specific to cardiac muscle and can be used to detect damage more quickly, allowing faster and more effective treatment.
MEANING IN MARKERS
MARKER NORMAL VALUE 0-3 ng/ml TIME INCREASED AFTER MI 4-8 hours PEAK TIME RETURN TIME CK-MB After 20 hours Remain elevated for up to 72 hours
70-200 IU/L
0-0.4 ng/mL 0-0.1 ng/mL 30 to 90 ng/ml
8-12 hours
3-6 hours 30 minutes4 hours
24-48 hours
14-20 hours 12-24 hours 6-7 hours
10-14 days
5-7 days 10-15 days After 24 hours
NURSING CONSIDERATIONS
Before CK measurement, withhold alcohol, aminocaproic acid, and lithium as ordered. Avoid administering IM injections. After any cardiac enzyme test, handle the collection tube gently to prevent hemolysis and send the sample t the lab immediately.
ECHOCARDIO -GRAPHY
ECHOCARDIOGRAPHY
It is used to examine the size, shape, and motion of cardiac structures. It is done using a transducer placed at an acoustic window (an area where bone and lung tissue are absent) on the patients chest. The transducer direct sounds waves toward cardiac structures.
2-D ECHOCARDIOGRAPHY
The UTZ beam rapidly sweeps through an arc, producing a cross-sectional, fan-shaped, view of cardiac structures. It is useful for recording lateral motion and providing the correct spatial relationship between cardiac structures.
ECHO ABNORMALITIES
Mitral stenosis Mitral valve prolapse Aortic insufficiency Wall motion abnormalities Pericardial effusion
NURSING CONSIDERATIONS
1. Explain the procedure to the patient and advise him to remain still during the test because movement can distort results. 2. After the procedure, remove the conductive gel from the skin.
CATHETERIZATION
CARDIAC
CARDIAC CATHERIZATION
It involves passing a catheter into the right, left, or both sides of the heart. It permits measurement of BP and blood flow in the chambers of the heart. Its used to determine valve competence and cardiac wall contractility and to detect intracardiac shunts. It also enables collection of blood samples and taking diagnostic films of the ventricles and arteries.
NURSING CONSIDERATIONS
BEFORE THE PROCEDURE:
1. Explain that this test is used to evaluate the function of the heart and its vessels. Instruct the patient to restrict food and fluids for at least 6 hours before the test. Tell him the procedure takes 1-2 hours and that he may receive a mild sedative during the procedure. 2. Tell the patient that the catheter is inserted into an artery or vein in the arm or leg. Then tell him hell experience a transient stinging sensation when a local anesthetic is injected to numb the incision site for catheter insertion. 3. Inform the patient that injection of the contrast medium through catheter may produce hot, flushing sensation or nausea that quickly passes; instruct him to follow directions to cough or breathe deeply.
NURSING CONSIDERATIONS
3. Make sure that the patient or a responsible family member has signed a consent form. Check for and tell the doctor about hypersensitivity to shellfish, iodine, or contrast media used in other diagnostic tests. 4. Discontinue anticoagulant therapy, as ordered, to reduce the risk of complications from bleeding. 5. Review activity restrictions that may be required of the patient after the procedure, such as lying flat with the limb extended for 4-6 hours and use of sandbags, if a femoral sheath is used. 6. Document the presence of peripheral pulses, noting their intensity. Mark the pulses so they may be easily located after the procedure.
NURSING CONSIDERATIONS
AFTER THE PROCEDURE: 1. Inspect the site for bleeding or oozing, redness, swelling, or hematoma formation. Maintain the patient on bed rest for 1-2 hours. 2. Enforce bed rest for 8 hours if no hemostatic device was used. If the femoral route was used for catheter insertion, keep the patients leg extended for 6-8 hours; at least 3 hours for antecubital fossa. 3. Monitor v/s every 15 minutes for 2 hours, then every 30 minutes for the next 2 hours, and then every hour for 2 hours. 4. Continually assess the insertion site for a hematoma or blood loss and reinforce the pressure dressing needed. 5. Administer IVF as ordered (usually 100 ml/hr) to promote excretion of the contrast medium. Monitor for signs of fluid overload. 6. Watch for signs of complications: chest pain, shortness of breath, abnormal HR, dizziness, diaphoresis, n/v, or extreme fatigue.
MONITORING
HEMODYNAMIC
HEMODYNAMIC MONITORING
It is used to assess cardiac function and determine the effectiveness of therapy by measuring: Cardiac output Mixed venous blood Oxygen saturation Intracardiac pressures Blood pressures
HEMORRHAGE
1. 2. 3.
1. 2. 3. 4. 5.
Tighten all connections Provide splint Flush line Estimate blood loss If catheter is removed, apply pressure and sterile dressing
CLOT FORMATION
AIR EMBOLISM
INFECTION
1.
2.
Change IVF solution every 4 hours and line set up and disposable transducer every 72 hours Daily dressing and site inspection
1. 2.
Sites: SUBCLAVIAN, JUGULAR, BASILIC, FEMORAL vein NORMAL MEAN PRESSURE: a. Water manometer: 1.34-8 cm H20 b. Mercury system: 1-6 mm Hg
NORMAL VALUES
PA CATHETER PORTS
The balloon inflation lumen inflates the balloon at the distal tip of the catheter for PAWP measurement. A distal lumen measures PA pressure when connected to a transducer and measure PAWP during balloon inflation. It also permits drawing of mixed venous blood samples. A proximal lumen measures RAP. Thermistor connector lumen contains temperature-sensitive wires, which feed information into a computer for CO calculation. Another lumen may provide a port for pacemaker electrodes or measurement of mixed oxygen saturation.
NORMAL PA WAVEFORMS
CARDIAC OUTPUT
MONITORING
CARDIAC OUTPUT
It is the amount of blood ejected by the heart in one minute. It is monitored to evaluate cardiac function. The normal range: 4-8 L/minute. CALCULATION: =
Stroke Volume (SV) is the volume of blood pumped from one ventricle of the heart with each beat (55-100 mL) Heart Rate (HR) refers to the speed of the heartbeat, specifically the number of heartbeats per unit of time (60-100 bpm)
CO MEASUREMENT
To measure the cardiac output, a solution is injected into the right atrium through a port on a PA catheter. The indicator solution (iced or room-temperature injectant) mixes with the blood as it travels through the RV into the PA, and a thermistor on the catheter registers the change in temperature of the flowing blood. A computer then plots the temperature change over time as a curve and calculates flow based in the area under the curve.